These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11043570)

  • 1. The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation.
    Martini JF; Piot C; Humeau LM; Struman I; Martial JA; Weiner RI
    Mol Endocrinol; 2000 Oct; 14(10):1536-49. PubMed ID: 11043570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
    Clapp C; Martial JA; Guzman RC; Rentier-Delure F; Weiner RI
    Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells.
    D'Angelo G; Martini JF; Iiri T; Fantl WJ; Martial J; Weiner RI
    Mol Endocrinol; 1999 May; 13(5):692-704. PubMed ID: 10319320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB.
    Tabruyn SP; Sorlet CM; Rentier-Delrue F; Bours V; Weiner RI; Martial JA; Struman I
    Mol Endocrinol; 2003 Sep; 17(9):1815-23. PubMed ID: 12791771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.
    Gonzalez C; Corbacho AM; Eiserich JP; Garcia C; Lopez-Barrera F; Morales-Tlalpan V; Barajas-Espinosa A; Diaz-Muñoz M; Rubio R; Lin SH; Martinez de la Escalera G; Clapp C
    Endocrinology; 2004 Dec; 145(12):5714-22. PubMed ID: 15358675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance.
    Piwnica D; Touraine P; Struman I; Tabruyn S; Bolbach G; Clapp C; Martial JA; Kelly PA; Goffin V
    Mol Endocrinol; 2004 Oct; 18(10):2522-42. PubMed ID: 15192082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells.
    Ferrara N; Clapp C; Weiner R
    Endocrinology; 1991 Aug; 129(2):896-900. PubMed ID: 1855480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice.
    Pan H; Nguyen NQ; Yoshida H; Bentzien F; Shaw LC; Rentier-Delrue F; Martial JA; Weiner R; Struman I; Grant MB
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2413-9. PubMed ID: 15223825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression.
    Lee H; Struman I; Clapp C; Martial J; Weiner RI
    Endocrinology; 1998 Sep; 139(9):3696-703. PubMed ID: 9724020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation.
    Tabruyn SP; Sabatel C; Nguyen NQ; Verhaeghe C; Castermans K; Malvaux L; Griffioen AW; Martial JA; Struman I
    Mol Endocrinol; 2007 Jun; 21(6):1422-9. PubMed ID: 17405903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases.
    Tabruyn SP; Nguyen NQ; Cornet AM; Martial JA; Struman I
    Mol Endocrinol; 2005 Jul; 19(7):1932-42. PubMed ID: 15746189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells.
    Clapp C; Weiner RI
    Endocrinology; 1992 Mar; 130(3):1380-6. PubMed ID: 1311239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) mice.
    Bentzien F; Struman I; Martini JF; Martial J; Weiner R
    Cancer Res; 2001 Oct; 61(19):7356-62. PubMed ID: 11585777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation.
    Nguyen NQ; Castermans K; Berndt S; Herkenne S; Tabruyn SP; Blacher S; Lion M; Noel A; Martial JA; Struman I
    PLoS One; 2011; 6(11):e27318. PubMed ID: 22087289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiostatic protein 16K human prolactin significantly prevents tumor-induced lymphangiogenesis by affecting lymphatic endothelial cells.
    Kinet V; Castermans K; Herkenne S; Maillard C; Blacher S; Lion M; Noël A; Martial JA; Struman I
    Endocrinology; 2011 Nov; 152(11):4062-71. PubMed ID: 21862622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein induces calpain-dependent cell death and ubiquitination of caspase 3 in HMEC-1 endothelial cells.
    Pörn-Ares MI; Saido TC; Andersson T; Ares MP
    Biochem J; 2003 Sep; 374(Pt 2):403-11. PubMed ID: 12775216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway.
    Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2004 May; 25(5):691-8. PubMed ID: 15132839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2.
    Schrantz N; Blanchard DA; Mitenne F; Auffredou MT; Vazquez A; Leca G
    Cell Death Differ; 1999 May; 6(5):445-53. PubMed ID: 10381635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
    Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC
    Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.